Aashiq M.N.M.

Mr. Aashiq M.N.M.

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 December 2023 in Engineering Proceedings
Verified
Conference Paper
Open access
PDF file
CKChamoda Tharindu Kumara
Chamoda Tharindu Kumara
SPSandunika Charuni Pushpakumari
Sandunika Charuni Pushpakumari
AUAshmini Jeewa Udhyani
Ashmini Jeewa Udhyani
AMAashiq M.N.M.
Aashiq M.N.M.
Hirshan RajendranHirshan Rajendran
Hirshan Rajendran
WKW.G.C.W. Kumara
W.G.C.W. Kumara
Coronavirus (COVID-19) is a fast-spreading virus-related disease. On 28 March 2022, Worldometer (COVID-19 live update) reported that there were about 482,338,923 COVID-19 cases and 6,149,387 fatalities worldwide. Moreover, there were about 416,884,712 recovered patients. The primary clinical mechanism currently utilized for COVID-19 identification is the Reverse Transcription–Polymerase Chain Reaction (RT-PCR). Hospitals only have small quantities of COVID-19 test kits available due to the daily increase in cases. As an alternative diagnosis possibility, an automatic detection system was implemented. A vigorous technique for the automatic COVID-19 identification is the deep learning approach. Chest X-ray (CXR) imaging is a modest tool that can be an alternate for diagnosing COVID-19-infected patients. With the use of deep learning, deep layer characteristics that are hidden from human sight may be observed using CXR imaging. One of the largest public databases, the “COVID-19 Radiography Database”, comprises 21,164 CXR images and was taken from Kaggle. To achieve the best accuracy in this work, data cleansing and the balanced dataset approach were applied. The primary goal of data cleansing is to remove duplicate CXR images from the database. The accuracy of three distinct pre-trained Convolutional Neural Networks (CNNs) was compared and then analyzed (Xception, InceptionV3, and MobileNetV2). Among other models, Xception achieved the best testing accuracy of 94.13% with plain lung CXR pictures. The Gabor filtering image enhancement approach was also employed to identify COVID-19. Only for the MobileNetV2 model did enhance CXR images perform significantly better for classification than plain lung CXR images. This study attempts to enhance the system’s accuracy to 100%, outperforming previous tests.

1 May 2025 in IEEE Access
Verified
Journal Article
Open access
AMAashiq M.N.M.
Aashiq M.N.M.
SHShaiful Hashim
Shaiful Hashim
FRFakhrul Zaman Rokhani
Fakhrul Zaman Rokhani
MHMarsyita Hanafi
Marsyita Hanafi
AHAhmed Faeq Hussein
Ahmed Faeq Hussein
Cardiovascular diseases (CVDs) are the leading cause of global death, with approximately 80% of such CVD mortalities occurring in low and middle-income regions. Early detection of cardiac abnormalities is essential for timely intervention and minimizing mortalities. Automated CVD detection methods are vital, particularly in areas with limited healthcare resources. However, most existing AI-based techniques lack three critical aspects: model interpretability, longer-duration analysis, and effective use of nonlinear time-frequency approaches, which are necessary for ECG signals due to their nonlinear, nonstationary, and multi-component nature. This study proposes explainable intelligent classifiers incorporated with a novel sequence of time-frequency energy Gini Index (GI) features from the QRS complexes of ECG signals to address these challenges and enable early-stage CVD detection. These features are extracted using the Choi-Williams Time-Frequency method, reporting the first instance application of GI measures to nonlinear time-frequency distribution (TFD) for ECG analysis. Features are computed from one-minute windows, covering 30 minutes of ECG recordings. These interpretable features provide clear insights into normal and abnormal ECG patterns. The proposed method was trained and validated using the MIT-BIH Arrhythmia and Fantasia-Normal databases. Eight machine learning classifiers, including SVM, Random Forest, XGBoost, Gaussian Naïve Bayes, KNN, LinearBoost, CatBoost, and Logistic Regression were tested. The best model achieved 100% sensitivity, 94.4% accuracy, 95.24% F1-score, 90% precision, and 92.59% AUC on the test dataset. High sensitivity ensures reliability for medical screening by reducing False Negatives, making the approach suitable for integration into any type of smart device for accurate online and offline monitoring of CVD abnormalities.

5 August 2025 in IEEE Access
Verified
Journal Article
Open access
SOSalami Safran Olugbenga
Salami Safran Olugbenga
AMAashiq M.N.M.
Aashiq M.N.M.
Siti Anom AhmadSiti Anom Ahmad
Siti Anom Ahmad
MTMaw Pin Tan
Maw Pin Tan
YZYuanyuan Zhao
Yuanyuan Zhao
FRFakhrul Zaman Rokhani
Fakhrul Zaman Rokhani
Cognitive frailty (CF), defined as the co-existence of physical frailty and cognitive impairment without dementia, has two subtypes: reversible cognitive frailty (RCF) and potentially reversible cognitive frailty (PRCF). This study aimed to develop machine learning models for the early prediction of CF by incorporating both RCF and PRCF into a unified framework. Data from 2,173 participants were sourced from the AGELESS and MELoR cohort studies, including clinical, blood, urine, and health status information. Participants were grouped into six CF categories based on the FRAIL scale and MoCA scores from 2020 and 2022. Seven machine learning models, SVM, LR, KNN, RF, CART, LDA, and GNB, were trained using clinical, blood, and urine datasets. Clinical variables outperformed other data types, with SVM, LR, and CART models achieving 95% accuracy and AUC scores of 1.0, while blood- and urine-based models showed lower performance (AUCs of 0.8 and 0.89, respectively). F1 scores and ROC analysis confirmed the robustness of the clinical models, and cross-validation showed consistent performance on unseen data, indicating no overfitting. These findings highlight the superior predictive power of clinical variables for identifying both subtypes of CF, supporting their potential for use in early, accurate diagnosis. Nonetheless, external validation using independent cohorts is recommended to ensure broader applicability.

23 October 2026 in Journal of Stored Products Research
Verified
Journal Article
Closed access
ADAbhishek Dasore
Abhishek Dasore
NHNorhashila Hashim
Norhashila Hashim
RSRosnah Shamsudin
Rosnah Shamsudin
HMHasfalina Che Man
Hasfalina Che Man
AMAashiq M.N.M.
Aashiq M.N.M.